OLR1 and acne: By identifying OLR1 as a critical receptor involved in the sebosuppressive effects of ALA-PDT, we propose that OLR1 could serve as a novel therapeutic target for enhancing the efficacy of photodynamic therapy in treating acne vulgaris.